In the fast-paced world of technology, 2023 marked the mainstream emergence of generative AI, creating a buzz across various industries.
Microsoft-backed ChatGPT led the way in late 2022, and competitors have entered the scene ever since.
This month, Alphabet, Google’s parent company, introduced Gemini, an AI set to integrate into various Google products, claiming superiority over the current ChatGPT version.
OpenAI, the creator of ChatGPT, responded by promising a more powerful version in the coming year.
Investors are pouring funds into generative AI start-ups, with global venture capital reaching $21.4 billion by September 2023, surpassing the entire investment of $5.1 billion in 2022.
Despite the hype, some caution that obstacles, such as high development costs and potential legal challenges, may slow the rapid progress of generative AI.
Electric Vehicle Outlook 2024
2024 is projected to be a challenging year for electric vehicle (EV) manufacturers, following production pauses by major players like Ford, GM, and Tesla in late 2023.
A “brutal” market, characterized by a price war and supply chain issues, was described by Mercedes-Benz.
Despite this, the UK is set to launch its one-millionth all-electric car in the first quarter of 2024, making it the second market to reach this milestone after Germany.
Analysts anticipate a tough year for EV sales in Europe, except in the UK, where the zero-emission vehicle (ZEV) mandate could create a buyer’s market, making EVs more accessible through financing deals and higher trim levels.
Humanoid Robots
Humanoid robots might become more practical in 2024, with Tesla’s Optimus aiming to perform basic factory jobs by the year’s end.
Competitors like Amazon’s Digit and Sanctuary AI’s Phoenix are also making strides in the field, with tasks ranging from warehouse operations to bag packing.
Weight-Loss Pharmaceuticals
Novo Nordisk’s weight-loss drug, Wegovy, has become a blockbuster in the pharmaceutical realm, leading the company to invest billions in expanding production facilities.
With the tablet version on the horizon, Eli Lilly’s Mounjaro gaining approval, and Pfizer seeking approval for its weight-loss pill, the weight-loss pharmaceutical market is set for increased competition in 2024.
https://www.youtube.com/watch?v=xDclQczbaN0
Who Is Brenda Czeda? Height, Weight, Education, Career, Net Worth
Tech Insights 2024: AI And Electric Vehicle Developments, Tech Insights 2024: AI And Electric Vehicle Developments